Michael Bromberg, MD, PhD, Chief of the Section of Hematology at Temple University Hospital, discussed with HealthCentral two newly approved gene therapies for patients with the genetic blood disorder transfusion-dependent beta thalassemia.
Michael Bromberg, MD, PhD, Chief of the Section of Hematology at Temple University Hospital, discussed with HealthCentral two newly approved gene therapies for patients with the genetic blood disorder transfusion-dependent beta thalassemia.
Theresa J.C. Pazionis, MD, was interviewed by Becker’s Spine Review to discuss her work in 3D-printed spinal devices.
Read More6abc and The Philadelphia Inquirer covered an event hosted by the Frazier Family Coalition for Stroke Education and Prevention called “Soul Food Cooking with a Twist.”
Read More